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ABSTRACT The scavenger receptor MARCO is expressed in several subsets of naive
tissue-resident macrophages and has been shown to participate in the recognition
of various bacterial pathogens. However, the role of MARCO in antiviral defense is
largely unexplored. Here, we investigated whether MARCO might be involved in the
innate sensing of infection with adenovirus and recombinant adenoviral vectors by
macrophages, which elicit vigorous immune responses in vivo. Using cells derived
from mice, we show that adenovirus infection is signiﬁcantly more efﬁcient in
MARCO-positive alveolar macrophages (AMs) and in AM-like primary macrophage
lines (Max Planck Institute cells) than in MARCO-negative bone marrow-derived mac-
rophages. Using antibodies blocking ligand binding to MARCO, as well as gene-
deﬁcient and MARCO-transfected cells, we show that MARCO mediates the rapid ad-
enovirus transduction of macrophages. By enhancing adenovirus infection, MARCO
contributes to efﬁcient innate virus recognition through the cytoplasmic DNA sensor
cGAS. This leads to strong proinﬂammatory responses, including the production of
interleukin-6 (IL-6), alpha/beta interferon, and mature IL-1. These ﬁndings contrib-
ute to the understanding of viral pathogenesis in macrophages and may open new
possibilities for the development of tools to inﬂuence the outcome of infection with
adenovirus or adenovirus vectors.
IMPORTANCE Macrophages play crucial roles in inﬂammation and defense against
infection. Several macrophage subtypes have been identiﬁed with differing abilities
to respond to infection with both natural adenoviruses and recombinant adenoviral
vectors. Adenoviruses are important respiratory pathogens that elicit vigorous innate
responses in vitro and in vivo. The cell surface receptors mediating macrophage
type-speciﬁc adenovirus sensing are largely unknown. The scavenger receptor MARCO is
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expressed on some subsets of naive tissue-resident macrophages, including lung al-
veolar macrophages. Its role in antiviral macrophage responses is largely unexplored.
Here, we studied whether the differential expression of MARCO might contribute to
the various susceptibilities of macrophage subtypes to adenovirus. We demonstrate
that MARCO signiﬁcantly enhances adenovirus infection and innate responses in
macrophages. These results help to understand adenoviral pathogenesis and may
open new possibilities to inﬂuence the outcome of infection with adenoviruses or
adenovirus vectors.
KEYWORDS IL-1, MARCO, MPI cells, adenovirus, cGAS, cytokines, innate immunity,
macrophages, scavenger receptor
Virus-macrophage interactions play crucial roles in the pathogenesis and control ofviral infections. Since intracellular pathogen sensing is central in the elicitation of
early antiviral responses, early interactions of viral pathogens with innate immune cells,
including macrophages, contribute signiﬁcantly to effective antiviral defense mecha-
nisms (1, 2). Macrophages differ in their origin, development, and function (3). Since
viruses use a range of surface molecules as receptors and facilitators for cellular entry
(4), cell surface heterogeneity in macrophage subsets is expected to inﬂuence patho-
gen entry and also the innate stimulatory activity of different virus types.
Adenoviruses (Ads) are important, nonenveloped, double-stranded-DNA-containing
pathogens. Replication-defective recombinant Ad vectors are used for vaccination
against infectious diseases, for cancer immunotherapy, and for studies of virus-host cell
interactions (5, 6). Human Ad species C members (e.g., Ad type 2 [Ad2] and Ad5) are
important tools in such applications (7, 8). Ad infection elicits potent innate immune
responses in vitro and in vivo, and mononuclear phagocytes are major contributors to
these responses (9). Different populations of tissue macrophages and dendritic cells
produce high levels of proinﬂammatory cytokines and type I interferons (IFNs) in
response to Ad particles. These responses can critically inﬂuence the course of natural
Ad infection or the outcome of Ad vector applications, for example, by tuning the
expression of cell surface receptors on epithelial cells (10).
Virus entry triggers signaling pathways that play key roles in Ad-elicited proinﬂam-
matory responses, but the contributions of cellular factors that mediate Ad entry into
resident tissue macrophages, such as surface receptors, are incompletely understood
(11, 12). The coxsackievirus-Ad receptor (CAR) and integrins are the main surface
receptors for Ad entry into epithelial cells. In vitro studies have shown that Ads attach
to these cells by the interaction of the viral ﬁber knob with CAR, leading to the exposure
of membrane-lytic protein VI (13). Viruses are subsequently internalized via receptor-
mediated endocytosis, escape to the cytosol, and import viral DNA into the nucleus (12,
14–17). In liver cells in vivo, Ad particles can also be internalized via binding to cell
membrane heparan sulfate proteoglycans through blood factors (18, 19).
While macrophages and other myeloid cells do not express CAR, interactions with
other host factors have been shown to contribute to Ad entry into these cells. This
includes opsonization by serum factors such as antibodies or complement, leading to
viral entry into macrophages and neutrophils via ubiquitously expressed Fc and com-
plement receptors (20, 21). Contributions to virus entry by serum lactoferrin and
coagulation factor X have also been reported (19, 22).
Furthermore, the scavenger receptors (SRs) SR-A and SREC1, members of a family of
pattern recognition receptors with broad ligand speciﬁcity that are expressed ubiqui-
tously on macrophages, have been reported to play a role in Ad uptake into macro-
phages (21–25).
Several sensors have been implicated in the innate activation of mononuclear
phagocytes by Ads. Toll-like receptor 2 (TLR2), TLR4, and TLR9 have been shown to
contribute to Ad-induced cytokine production (26, 27). Efﬁcient triggering of innate
responses was shown to require endosomal escape and cytoplasmic detection of the
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virus (28). Recently, the cyclic GMP-AMP synthase (cGAS) has been identiﬁed as a major
cytosolic innate sensor for Ads (29, 30).
Previously, we have demonstrated that the production of innate cytokines in
response to respiratory pathogens, including Ads, is signiﬁcantly stronger in murine
AMs and in nontransformed, granulocyte-macrophage colony-stimulating factor-
dependent, self-renewing, AM-like macrophages (designated Max Planck Institute
[MPI] cells) than in bone marrow-derived macrophages (BMMs) (31). Similar to AMs, MPI
cells express high levels of the SR class A protein MARCO, while rather Ad-insensitive
BMMs do not express this SR. Functionally, MARCO has been shown to directly enhance
antibacterial macrophage responses (32). Whether it plays a similar role in macrophage
responses to viral infections has not yet been investigated.
In this study, we investigated the possibility that MARCO expression enhances the
susceptibility of macrophages to Ad. Using several mouse macrophage types, we show
that the presence of MARCO allows rapid Ad gene expression and strong virus-
stimulated innate responses while blockage or a lack of MARCO results in strong
impairment of these processes. Thus, MARCO is involved in innate Ad recognition and
the elevated Ad sensitivity of MARCO-expressing macrophages is due to the expression
of this receptor on the cell surface.
RESULTS
Ad entry into and activation of innate signaling in MPI cells and AMs, unlike
those in BMMs, are fast and efﬁcient. Intracellular sensing of incoming virus particles
is a major process in the triggering of antiviral responses. We tested the efﬁciency of
adenoviral transduction of various macrophage types, i.e., alveolar macrophages (AMs),
BMMs, and MPI cells, by using a nonreplicating, green ﬂuorescent protein (GFP)-
expressing Ad. The lung epithelial cell line A549, which can be infected efﬁciently with
Ads, was also used as a positive control. Microscopic examination at 16 h postinfection
(p.i.) revealed that the majority of the MPI cells, AMs, and A549 cells were strongly GFP
positive, while BMMs expressed GFP only weakly (Fig. 1A). The time course of GFP
expression in infected cells was analyzed by ﬂow cytometry, which showed that
GFP expression was already detectable at 6 h p.i. in A549 and MPI cells and AMs,
whereas BMMs were still GFP negative at 10 h p.i. (Fig. 1B). After 16 h, about 94 to 96%
of the A549 and MPI cells and AMs expressed GFP. In MPI cells and AMs, two
populations, moderately and strongly positive subsets, could be identiﬁed. In contrast,
FIG 1 Efﬁciency of Ad infection in different cell types. (A) GFP expression was analyzed in different cell
types 16 h p.i. with AdGFP by ﬂuorescence (top) and light (phase-contrast; bottom) microscopy. Bars,
50 m. (B) FACS analysis of GFP expression in infected cells at the time points indicated. The value at the
top of each graph is the frequency of GFP cells at 16 h p.i., and the gate indicates GFP cells.
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only 75% of the BMMs were weakly GFP positive by this late time point. These results
demonstrated faster and more efﬁcient transduction of MPI cells and AMs than of
BMMs.
To compare the kinetics and strength of the Ad-induced signaling and cytokine
responses in the different macrophage types, we measured the activation of the
transcription factors IRF3 and NF-B, the activation of the mitogen-activated protein
kinase p38, and the secretion of IFN-/ and IL-6 at various time points after Ad
inoculation. Activation of p38 and IRF3 was analyzed with phosphospeciﬁc antibodies,
whereas nuclear translocation of NF-B subunit p65 was used to analyze NF-B
activation. In MPI cells, the strong activation of p38, IRF3, and NF-B was ﬁrst detectable
at 1 to 2 h p.i. and persisted for up to 8 h for NF-B and at least up to 10 h for IRF3 and
p38 (Fig. 2A). In contrast, in BMMs weak, delayed, and shorter activation of p38 was
detected between 2 and 6 h and activation of IRF3 and NF-B was not detected at all
(Fig. 2A). Consistent with this, Ad-infected MPI cells exhibited early and strong produc-
tion of type I IFN and IL-6, while only marginal production of these cytokines was
observed at 16 h after the inoculation of BMMs (Fig. 2B). Murine AMs (Siglec F, F4/80,
and CD11c triple-positive cells), which constitute the vast majority of freshly isolated
bronchoalveolar lavage (BAL) cells (see Fig. S1A in the supplemental material), were
also infected with Ad. Similar to the infection of MPI cells, and unlike that of BMMs, they
exhibited early and strong phosphorylation of p38 and IRF3 (Fig. S1B) and a strong
cytokine response (Fig. S1C).
In summary, these results document a large difference in the activation of Ad-
stimulated innate signaling between MPI cells/AMs and BMMs, and this correlates with
the efﬁciency of Ad transduction.
Cytoplasmic sensing by cGAS mediates Ad-stimulated innate responses in MPI
cells. The initiation of Ad-induced innate responses has been attributed to the cell
surface receptors TLR2 and TLR4, endosomal TLR9, and more recently to the cytoplas-
mic DNA sensor cGAS (26, 27, 29). MPI cells deﬁcient in both TLR2 and TLR4 showed no
reduction of IL-6 production following Ad infection (Fig. 3A). Furthermore, infection of
MPI cells with the Ad2 ts1 mutant, which is taken up into endosomes but does not
enter the cytosol (33), did not induce detectable cytokine production (Fig. 3A), indi-
cating that virus sensing at the plasma membrane or in the endosomes is not sufﬁcient
for induction of the innate responses in MPI cells. To test the role of cytoplasmic cGAS,
we used short hairpin RNA (shRNA) to knock down this sensor in MPI cells. A C911
FIG 2 Early immune activation of MPI cells and BMMs p.i. with AdGFP. (A) Western blot analysis of the
cytoplasmic (p-p38, p-IRF3) and nuclear (NF-B p65) cell fractions at the time points indicated. (B)
Cytokine production was measured by ELISA in cell-free supernatants at the time points indicated.
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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mismatch shRNA was used as a control (34). AdGFP transduction of cGAS knockdown
cells resulted in signiﬁcantly less cytokine production than in Ad-transduced MPI cells
expressing the C911 control shRNA (Fig. 3B). In a control experiment, cytokine produc-
tion in response to lipopolysaccharide (LPS) was not reduced in cGAS knockdown MPI
cells (Fig. S2A). Notably, the knockdown of cGAS had no negative inﬂuence on the
AdGFP transduction of MPI cells, as measured by GFP expression in infected MPI cells
(Fig. S2B).
Ad induces production of mature IL-1 in MPI cells but not in BMMs. We have
previously demonstrated that LPS-stimulated MPI macrophages, unlike BMMs, secrete
substantial amounts of IL-1 (31). Ad infection also induced a signiﬁcant IL-1 re-
sponse, which peaked 8 h after inoculation, and a marginal IL-1 response in MPI cells,
but not in BMMs (Fig. 4A). We tested whether Ad infection also induces the maturation
of these cytokines. For this purpose, we infected MPI cells and BMMs with Ad and
analyzed the IL-1 and IL-1 forms in cell lysates by Western blotting at different times
FIG 3 Ad-induced cytokine production in MPI cells is independent of TLR2 and TLR4 but dependent on
cGAS. (A) IL-6 induction in WT and TLR2/TLR4/ MPI cells p.i. with WT Ad2 or mutant Ad2 ts1. (B)
Cytokine induction in cGAS knockdown MPI cells inoculated with AdGFP or mock infected for 16 h.
FIG 4 Ad-induced IL-1 production in MPI cells and BMMs. (A) Induction of IL-1 and IL-1 in cell-free
supernatants of MPI cells and BMMs after Ad infection at the time points indicated. (B) Western blot
analysis of MPI and BMM cell lysates at the time points indicated. GAPDH, glyceraldehyde-3-phosphate
dehydrogenase.
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p.i. Ad infection resulted in the processing of preexisting immature IL-1 between 0.5
and 8 h p.i. and in the accumulation of pro-IL-1 starting after 4 h of stimulation
(Fig. 4B). Furthermore, immature IL-1, but not the mature IL-1 form, was induced in
Ad-infected MPI cells at later time points (4 to 16 h p.i.) (Fig. 4B). Finally, no induction
of IL-1 or IL-1 was detectable in lysates of Ad-infected BMMs.
Blocking of the SR MARCO on MPI cells and AMs interferes with Ad entry and
induction of cytokine production. We investigated whether the differential expres-
sion of a ligand recognition receptor might be responsible for the greater sensitivity to
Ad of MPI cells and AMs than of BMMs. As expected, the mRNA for CAR, the main
receptor responsible for the uptake of species C Ads in most nonimmune cells, is not
detectable in MPI cells and BMMs (Fig. S3A and B). Although the SRs SR-A and SREC1
have been implicated in Ad entry into macrophages (21–25), analysis of mRNA levels in
MPI cells and BMMs did not show strong expression of these genes for these SRs in MPI
cells (Fig. S3A and B), in agreement with our previously obtained microarray data (31).
This suggested that these proteins are not involved in the differential sensitivity to
Ad (Fig. S3). As shown in Fig. S3A to C and demonstrated previously (31, 35), another
related microbial sensor, the SR MARCO, is highly expressed in MPI cells but absent
from resting BMMs. SR-A is weakly expressed on both cell types (Fig. S3C). We also
tested MARCO expression on various tissue-resident macrophages. We found no sig-
niﬁcant MARCO expression on liver and skin macrophages. However, peritoneal mac-
rophages, AMs, and spleen marginal-zone macrophages exhibited substantial levels of
MARCO on their surface (Fig. S4). These cell types have previously been reported to be
very efﬁciently infected by Ads (36–39). We tested the possible involvement of MARCO
in Ad transduction and in the elicitation of innate responses. For this purpose, we
compared the GFP expression and IL-1 and IL-6 responses of AdGFP-infected MPI cells
and AMs in the presence or absence of a monoclonal antibody that blocks ligand
binding to MARCO (40). Preincubation for 30 min with an anti-MARCO antibody, but
not with a control antibody, almost completely abolished both the AdGFP transduction
and the virus-induced cytokine responses of these cell types (Fig. 5A and B). These
results suggested a crucial role for MARCO in Ad sensing in MPI cells and AMs.
Several serum proteins have previously been shown to mediate Ad uptake by
myeloid cells (20, 22); however, SRs mediate ligand internalization without their help
(32). So far, the Ad transduction of macrophages in this study was carried out in the
presence of fetal calf serum (FCS). As shown in Fig. 5C, the absence of FCS did not
reduce the GFP expression (top) or the IL-6 response (bottom) of the infected cells.
These results suggest that MARCO-expressing macrophages do not need opsonizing
proteins to sense Ads.
MARCO deﬁciency drastically reduces the Ad transduction rate and the reac-
tivity of MPI cells and AMs to the virus. To test the importance of MARCO for Ad
transduction, we generated an MPI macrophage line from MARCO/ mice. As ex-
pected, these cells expressed macrophage markers and responded to LPS (TLR4 ligand)
and FSL-1 (TLR2 ligand) similarly to wild-type (WT) MPI cells (Fig. S5A and B). Impor-
tantly, however; compared to WT MPI macrophages, MARCO/ cells showed a strong
reduction of Ad transduction (Fig. 6A and C) and Ad-stimulated cytokine responses
(Fig. 6B), while the Ad infection of MARCO-deﬁcient BMMs was not signiﬁcantly
reduced (Fig. 6C). A similar Ad-insensitive phenotype was also exhibited by two other
MARCO/ MPI cell lines generated independently (not shown). In addition, we
isolated AMs from WT, MARCO/, SR-A/, and MARCO//SR-A/ doubly deﬁcient
mice and infected them with AdGFP. Compared to WT cells, MARCO/ and MARCO//
SR-A/ AMs showed strongly reduced GFP expression (Fig. 6D) and lacked an IL-6
response (Fig. 6E). However, the loss of SR-A alone resulted in no reduction of GFP
expression and only a moderate decrease in the IL-6 response of infected AMs (Fig. 6E).
As expected, the expression of macrophage surface markers and the LPS responses of
WT and MARCO/ AMs were very similar (Fig. S5C and D). We also tested if MARCO
expression contributes to Ad infection in peritoneal macrophages. We found that WT
cells can be efﬁciently infected and activated (IL-6 response) by AdGFP; however,
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MARCO deﬁciency resulted in a marked reduction of AdGFP transduction and of the
virus-triggered IL-6 response (Fig. 7). These results indicate that the absence of MARCO,
but not SR-A, severely reduces Ad transduction and the innate responses in these
macrophage types.
Transfection of MARCO in macrophages leads to increased Ad sensitivity. To
provide further evidence of the importance of MARCO, we transfected the murine RAW
264.7 macrophage line, which does not express MARCO (Fig. S6A, right), with a plasmid
expressing full-length murine MARCO or with the same expression vector lacking
MARCO. In both cases, expression of the cotransfected reporter tomato gene allowed
discrimination between transfected (tomato-positive) and untransfected (tomato-
negative) cells. As shown in Fig. 8A, both transfections yielded approximately 33%
tomato-positive cells at the time of analysis. Transfection of RAW 264.7 cells with the
MARCO-expressing plasmid resulted in MARCO surface expression only in tomato-
positive cells (Fig. S6A, left). MARCO was absent from both tomato-positive and
tomato-negative cells transfected with the control plasmid (Fig. S6A, left). MARCO- and
control-transfected cells were infected with AdGFP and analyzed by ﬂow cytometry for
GFP and tomato expression at 8 h postinoculation. While 50% of the MARCO-
transfected, tomato-positive cells expressed GFP, 10% of the control-transfected,
tomato-positive cells expressed GFP, indicating a dramatic increase in Ad transduction
due to the expression of MARCO. Pearson’s data analysis revealed a moderate positive
correlation (r  0.34; P  0.0001) of GFP and tomato expression in MARCO-transfected
RAW 264.7 cells, whereas no signiﬁcant correlation (r  0.02; P  0.3361) was found
in control-transfected cells (Fig. S6B). Furthermore, only cultures containing MARCO-
transfected cells produced high levels of IL-6 in response to AdGFP (Fig. 8B).
FIG 5 Ad transduction is strongly reduced by blocking MARCO but independent of serum factors. (A) GFP expression of cells infected with AdGFP in the
presence of a MARCO-blocking (right) or isotype antibody (left). Scale bars, 100 m. Top, ﬂuorescence microscopy; bottom, phase-contrast microscopy. (B)
Cytokine production of AdGFP-infected cells without antibody (control) and with a MARCO-blocking antibody or an isotype control. (C) GPF expression (top,
ﬂuorescence microscopy and corresponding phase-contrast microscopy) and IL-6 production (bottom) of AdGFP-infected MPI cells in the presence or absence
of FCS. Scale bars, 100 m. n.s., no statistically signiﬁcant difference.
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DISCUSSION
In the present study, we show that compared to BMMs, Ad infects mouse AMs and
AM-like MPI cells signiﬁcantly more strongly and with accelerated kinetics. This higher
infectivity rate explains why the Ad-induced proinﬂammatory cytokine responses of the
latter two macrophage types are substantially stronger than those of BMMs. Previous
studies indicated the possible involvement of cell surface TLR2 and TLR4, endosomal
TLR9, and non-TLR cytosolic virus sensing in the Ad-stimulated innate cytokine re-
sponses (26–28). Using gene-deﬁcient cells and the endosomal penetration-defective
mutant Ad2 ts1, we excluded a signiﬁcant involvement of TLR2, TLR4, and endosomal
sensing in the Ad-triggered responses of MPI cells. Earlier, we showed that the IFN-/
and IL-6 responses elicited by Ad strictly require viral endosomal escape (28). Here, we
show that Ad transduction is much more efﬁcient in MPI cells and AMs than in BMMs.
This implies that both the delivery of viral particles to the cytosol and the nuclear
import of viral DNA are efﬁcient in these cells. Since incoming viral DNA is frequently
and to a high level misdelivered to the cytosol (17), these results explain why the
triggering of innate signaling, such as the activation of NF-B, IRF-3, and p38, and the
induction of cytokine responses are faster and stronger in AMs and MPI cells than in
BMMs. The use of a different, less efﬁcient Ad internalization route in BMMs may be
responsible for the lack of detectability of NF-B and IRF-3 activation upon infection
and therefore for a very weak cytokine response. This is consistent with our previous
results and the results of others showing that signiﬁcantly higher Ad doses are
necessary to elicit potent cytokine responses in BMMs (28, 41).
The ﬁnding that Ad ts1, a mutant unable to enter the cytosol, does not induce an
IL-6 response in MPI cells conﬁrms that Ad-triggered responses need cytosolic virus
sensing. We show here that the knockdown of the cytosolic DNA sensor cGAS impairs
FIG 6 Effect of MARCO and SR-A deﬁciency on GFP expression and IL-6 production in macrophages infected for 18 h with AdGFP. (A)
Fluorescence microscopy (top) and corresponding phase-contrast microscopy (bottom) of infected MARCO/ and WT MPI cells. Scale
bars, 50 m. (B) IL-6 concentrations in supernatants of mock-infected and infected MARCO/ and WT MPI cells. (C) FACS comparison of
MARCO/ (gray-ﬁlled histogram) and WT (open histogram) MPI cells and BMMs at 16 h p.i. with AdGFP. (D) Fluorescence microscopy (top)
and corresponding phase-contrast microscopy (bottom) of mock-infected and infected AMs from different knockout mice. Scale bars,
100 m. (E) IL-6 concentrations in supernatants from mock-infected and infected AMs obtained from different knockout mice.
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the ability of Ads to activate MPI cells but does not affect adenoviral transduction
measured by GFP transgene expression. These ﬁndings are in agreement with the
major role of cytoplasmic virus sensing in MPI cells and with recent data showing that
cGAS is a dominant Ad sensor for the induction of IFN-/ but not for the nuclear
translocation of viral DNA in the murine MS1 and RAW 264.7 cell lines (29).
A likely explanation for the considerable differences between the kinetics of trans-
duction in AMs and MPI cells and those in BMMs was the differential expression of a
speciﬁc cell surface receptor. The SR MARCO, which is highly expressed in alveolar,
peritoneal, and MPI macrophages but not in BMMs (31), appeared to be a suitable
candidate. Indeed, our data demonstrate that loss of MARCO function, achieved either
by MARCO-blocking antibodies or by MARCO knockout in AMs and MPI macrophages,
FIG 7 GFP expression and IL-6 response of peritoneal cells from naive WT and MARCO/ mice infected
with AdGFP in vitro at 5 (top) and 16 (bottom) h p.i. Left, GFP expression in F4/80 cells (histograms).
Lines: black continuous, MARCO/ infected; black dotted, MARCO/ mock infected; red continuous,
WT infected; red dotted, WT mock infected. Right, IL-6 levels in supernatants of peritoneal cells.
FIG 8 Expression of MARCO in RAW 264.7 macrophages increases the infection efﬁciency of and cytokine response
to Ad. (A) Cells infected with AdGFP 16 h after transfection with murine MARCO or control plasmid DNA. Tomato
was used as a reporter for successfully transfected cells. Cells were analyzed by FACS at 8 h p.i. (B) IL-6 was analyzed
in cell-free supernatants 8 h after AdGFP infection.
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leads to severely reduced expression of Ad-transduced GFP and Ad-induced cytokine
production. Moreover, the introduction of MARCO into RAW 264.7 macrophages, which
do not express this protein, rendered the cells susceptible to Ad transduction and
contributed to increased cytokine production. Thus, MARCO is decisively involved in
the susceptibility of macrophages to Ad.
In the past, MARCO was shown to mediate the direct binding and internalization of
various nonopsonized particles. Antibodies to the ligand-binding domain of this re-
ceptor can block the interaction (35). In agreement, our data obtained with MPI cells
reveal that Ad infection and the elicitation of innate responses by Ad do not require the
presence of serum but can be inhibited by the MARCO-blocking antibody. Therefore, it
is likely that MARCO, similar to its role in the uptake of other microbial and nonmicro-
bial agents, mediates the internalization of Ad and thus promotes subsequent innate
responses. This may occur in cooperation with other plasma membrane proteins. A
cooperative action of CAR with integrins has been shown previously to initiate viral
entry into epithelial cells (13). Tissue-resident macrophages are very heterogeneous (3),
and variable expression of the factors responsible for Ad uptake and transduction,
including MARCO, may explain the observed wide range of Ad infectibility of polyclonal
MPI cells, AMs, and peritoneal macrophages.
SR-A, an SR related to MARCO and commonly expressed in various macrophage
types, has been reported to be involved in the uptake of Ad by macrophages (21–25).
Here, the comparison of GFP expression and cytokine production in AdGFP-infected
AMs from WT, MARCO/, SR-A/, and MARCO//SR-A/ mice indicated that this
receptor, either alone or in combination with MARCO, does not play a major role in the
Ad infection or activation of this macrophage type.
The identiﬁcation of MARCO involvement in the susceptibility of cells to Ad agrees
well with previous studies demonstrating that AMs and splenic marginal-zone macro-
phages, which strongly express MARCO, trap Ad particles very early p.i. (36, 39).
Ad-induced in vivo IL-1 production has been demonstrated previously in spleen. Di
Paolo et al. showed that MARCO-positive spleen marginal-zone macrophages are a
source of IL-1 in Ad-infected mice (36). They have also shown Ad-stimulated, IL-1-
mediated biological responses and the nuclear translocation of IL-1. However, pro-
teolytic maturation of this cytokine has not been demonstrated because similar to
N-terminal pro-piece ppIL-1, the immature IL-1 precursor can also readily translocate
into the nucleus (42). As shown previously (31) and in the present study, MARCO-
expressing AMs and MPI cells also exhibit a robust IL-1 response upon infection with
Ads. We provide direct evidence of the intracellular processing of IL-1 in Ad-infected
MPI cells. Both the full-length and processed IL-1 forms are biologically active,
although the proinﬂammatory activity of the mature IL-1 protein is higher (43). Since
Ads are important respiratory pathogens (44), and IL-1 has been shown to play a
central role in lung pathologies induced by several microbial agents (45, 46), the
elucidation of the mechanisms of Ad-induced IL-1 production in lung AMs is likely to
have medical signiﬁcance. Previously, di Paolo et al. (37) demonstrated that IL-1
produced by MARCO-expressing splenic marginal-zone macrophages is responsible for
splenic neutrophil recruitment and the subsequent elimination of virus-infected cells.
Thus, similar mechanisms may contribute to the AM-mediated control of respiratory Ad
infection.
While MARCO is known to be involved in the innate sensing of various bacteria,
much less is known about its role in virus infection and antiviral defense. MARCO was
recently shown to play a role in the entry of herpes simplex virus and vaccinia viruses
into keratinocytes, but macrophage infection and antiviral innate responses were not
investigated (47, 48). MARCO was also shown to indirectly suppress early antiviral
responses by removing cellular debris in the course of inﬂuenza virus infection (49). In
contrast, our studies demonstrate a positive role for MARCO in the direct mediation of
virus infection and triggering of antiviral responses in macrophages. Thus, MARCO may
inﬂuence antiviral innate responses in a virus type-speciﬁc manner.
The expression of MARCO in speciﬁc subsets of naive tissue-resident macrophages
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can be important for the primary sensing of naturally occurring viral infections. AMs
represent an early line of defense against respiratory pathogens; thus, the mechanisms
shown here may critically inﬂuence the early stages of natural Ad infection. In addition,
MARCO expression can be induced by inﬂammatory stimuli in macrophages normally
not expressing this receptor (50). This may broaden the macrophage types contributing
to the clearance of viral pathogens during the later phases of infection.
Our ﬁndings imply potential beneﬁcial and harmful effects in medical applications
using recombinant Ads. MARCO-mediated Ad infection of mononuclear phagocytes
could contribute directly to efﬁcient antigen processing and presentation. The cytokine
responses induced by the vector could also provide adjuvant effects for vaccination.
However, MARCO-mediated innate responses may be damaging, if the inﬂammatory
response is too strong. Furthermore, certain MARCO-sensed pathogens, such as Ad and
mycobacteria, induce hypersensitivity to LPS and other TLR ligands (51–53). Exposure
of hypersensitive individuals to TLR-triggering pathogens may lead to uncontrolled
inﬂammatory reactions and, in the worst case, to septic shock and death (54).
Our ﬁndings present a new target for further analyses of Ad-macrophage interac-
tions. Future studies delineating the details of the Ad-MARCO interaction may provide
tools to beneﬁcially inﬂuence both naturally occurring Ad infections, as well as thera-
peutic approaches utilizing this viral vector.
MATERIALS AND METHODS
Mouse strains. WT, MARCO/, SR-A/, and MARCO//SR-A/ C57BL/6 mice (50) were bred
under speciﬁc-pathogen-free conditions at the Max-Planck Institute in Freiburg or at the University
Hospital of the Rheinisch-Westfälische Technische Hochschule in Aachen. Knockout mice strains were
originally provided to S.G. by K. Tryggvason, Karolinska Institute, Stockholm, Sweden. Procedures were
in accordance with institutional, state, and federal guidelines on animal welfare.
Cell culture, Ad infection, and MARCO blocking. Murine AMs were isolated by BAL, and BMMs and
fetal liver-derived MPI cells were generated as previously described (31). Murine peritoneal cells were
obtained by lavage with 5 ml of phosphate-buffered saline (PBS). Murine spleen cell suspensions were
obtained by mechanical disintegration. To obtain skin cells, mouse ears were digested with Liberase
Thermolysin Medium (TM; Roche) as described in reference 55. Minced mouse livers were digested with
Liberase TM (Roche) for 30 min at 37°C, and Kupffer cells were further enriched by gradient centrifuga-
tion as described in reference 56. A549 adenocarcinoma-derived human alveolar basal epithelial cells and
RAW 264.7 murine macrophages were cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Gibco)
supplemented with 10% FCS (Biochrom), 100 g/ml streptomycin (Gibco), 100 U/ml penicillin (Gibco),
and 10 mM HEPES (Gibco). For the induction of cytokines, all cell types were used at a density of 5 
105/ml and plated on 96-well microtiter plates (Nunc) or 6-well plates (Nunc).
For Ad infection, replication-deﬁcient, GFP-expressing species C human Ad5 (AdGFP), species C
human WT Ad2, or mutant Ad2 ts1 was used. All viruses were used at a concentration of 1,000
particles/cell if not stated otherwise. GFP transduction was assessed by ﬂuorescence and phase-contrast
microscopy or ﬂuorescence-activated cell sorter (FACS) analysis. The viruses were propagated and
puriﬁed by CsCl2 density gradient ultracentrifugation as previously described (57). The concentration of
virus particles was determined with a spectrophotometer. Optical density at 260 nm (OD260)  OD330 
1 corresponds to 1012 virus particles/ml, and the ratio of viral particles to PFU was 20:1.
LPS from Salmonella enterica subsp. enterica serovar Minnesota R595 (Enzo Life Sciences) was used
at a concentration of 100 ng/ml. MARCO ligand binding was blocked by incubation of cells with puriﬁed
anti-mouse MARCO antibody (clone ED31; AbD Serotec) at a concentration of 20 ng/l for 30 min prior
to AdGFP infection. Puriﬁed rat anti-mouse IL-4 antibody (clone 11B11; BD Biosciences) was used as an
isotype control.
shRNA-mediated knockdown of cGAS in retrovirus-transduced MPI cells. Plasmids pENTRpTER
(430-1) (Addgene plasmid no. 17453) and pCQXIN X2 DEST (w310-1) (Addgene plasmid no. 17399) were
generously provided by Eric Campeau, and a previously published protocol was followed (58). Viral RNA
interference for mcGAS and its C911 control was established as previously described (34). The following
oligonucleotides for mcGAS and its C911 control (adapted from reference 59) were designed with the
Invitrogen shRNA Block-iT tool (Life Technologies, Inc.) and purchased from Microsynth AG, Balgach,
Switzerland: mshcGAS_for, 5= GATCCCGGATTGAGCTACAAGAATAGTGTGCTGTCCTATTCTTGTAGCTCAATC
CTTTTTGGAAA 3=; mshcGAS_rev, 5= AGCTTTTCCAAAAAGGATTGAG CTACAAGAATAGGACAGCACACTATT
CTTGTAGCTCAATCCGG 3=; mshcGAS_ C911_for, 5= GATCCCGGATTGAGGATCAAGAATAGTGTGCTGTCCTA
TTCTTGATCCTCAATCCTTTTTGGAAA 3=; mshcGAS_C911_rev, 5= AGCTTTTCCAAAAAGGATTGA GGATCAA
GAATAGGACAGCACACTATTCTTGATCCTCAATCCGG 3=.
shRNAs were cloned into entry vector pENTRpTER and recombined into Moloney murine leukemia
virus destination vector pCQXIN X2 DEST by Gateway cloning with LR Clonase. Plasmids were validated
by sequencing. Vesicular stomatitis virus G glycoprotein-pseudotyped murine leukemia virus retroviruses
were generated in HEK 293T cells by the standard procedure and used to produce stably transduced MPI
cells with G418 selection. The knockdown efﬁciency was 80%.
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FACS analysis. Nonspeciﬁc binding was blocked by preincubation of cells with anti-CD16/CD32
antibody (clone 93; BioLegend) in 1% goat serum in PBS. MARCO was detected with puriﬁed mouse
MARCO antibody (ED31; AbD Serotec) in combination with Alexa Fluor 647-conjugated goat anti-rat IgG
(Molecular Probes). Fluorophore-conjugated CD11b (M1/70), CD14 (Sa14-2), CD11c (N418), F4/80 (BM8),
and CD45 (30-F11) antibodies were from BioLegend; Siglec F (E50-2440) antibody was from BD Biosci-
ences; and SignR1 (ERTR9) and SR-A (2F8) antibodies were from AbD Serotec. Data were acquired on a
BD FACSCanto II cytometer and analyzed with FlowJo software (TreeStar).
Western blotting. Cell lysates were prepared in the presence of phosphatase inhibitor mixture II
(Sigma), a protease inhibitor cocktail (Sigma), and phenylmethylsulfonyl ﬂuoride (Sigma) with 100 l of
the respective lysis buffer per 106 cells. Radioimmunoprecipitation assay buffer (20 mM Tris [pH 7.5],
150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 1 mM EDTA, 0.1% SDS) was used to prepare whole-cell
lysates, or the cells were fractionated for cytosolic and nuclear fractions as previously described (31). The
quality of fractionation was checked with anti-glyceraldehyde-3-phosphate dehydrogenase (6C5; Acris
Antibodies) and polyclonal rabbit anti-histone 3 (Merck Millipore) antibodies as described previously (31).
Protein samples were blotted onto nitrocellulose membranes after denaturing SDS-polyacrylamide gel
electrophoresis. Rabbit anti-NF-B p65 (C-20; Santa Cruz Biotechnology), rabbit anti-phospho-IRF3
(Ser396) (4D4G; Cell Signaling Technology, Inc.), rabbit anti-phospho-p38 mitogen-activated protein
kinase (Thr180/Tyr182) (12F8; Cell Signaling Technology, Inc.), polyclonal goat anti-IL-1 (R&D
Systems), hamster anti-IL-1 (ALF-161; Santa Cruz Biotechnology), hamster anti-IL-1 (B122; R&D
Systems) horseradish peroxidase-conjugated goat anti-mouse and goat anti-rabbit IgG (both Cell
Signaling Technology, Inc.), mouse anti-hamster IgG (Santa Cruz Biotechnology), and rabbit anti-
goat IgG (Jackson ImmunoResearch, Inc.) antibodies were used for immunoblotting. Blots were
developed with the SuperSignal West Pico chemiluminescent substrate (Thermo Scientiﬁc).
Cytokine detection. IL-6, IL-1, and IL-1 were quantiﬁed in cell-free culture supernatants by
enzyme-linked immunosorbent assay (ELISA) with antibody pairs from BD Pharmingen (IL-6, IL-1) and
EBioscience (IL-1) in accordance with the instructions of the manufacturer. IFN-/ was measured with
reference to a recombinant mouse IFN- standard with an established luciferase expression-based
bioassay as previously described (28).
Transfection. The mammalian expression vector pCmarcoiT was used to express the full-length
murine MARCO protein. To construct the vector, full-length MARCO cDNA was ampliﬁed from MPI cell
cDNA with forward primer 5= GCCATGGGAAGTAAACAACTCC 3= and reverse primer 5= GTCAGGAGCATT
CCACACCCGCA 3= and cloned to give a cytomegalovirus-driven bicistronic transcript with the tandem-
dimer tomato gene (referred to here as tomato) expressed from an internal translation initiation site. This
allows identiﬁcation by FACS and analysis of the transfected cells. RAW 264.7 cells were transfected with
TurboFect Transfection Reagent (Thermo Scientiﬁc) in accordance with the manufacturer’s instructions.
Quantitative RT-PCR. RNA was prepared with Tri reagent (Sigma) in accordance with the manufac-
turer’s instructions. SuperScript II reverse transcriptase (Invitrogen) was used to reverse transcribe 2 g
of RNA. Real-time reverse transcription (RT)-PCR was performed with the LightCycler 480 SYBR green I
master kit (Roche) and the Roche LightCycler 480 instrument with the following primers: Marco, forward
primer 5= ACCAGGCCTACCAGGTTTG 3= and reverse primer 5= ACCCTGCACTCCAGGTTTT 3=; Sra, forward
primer 5= CAGTCAGCATCCTCTTGTTCA 3= and reverse primer 5= GTCTTCTTTACCAGCAATGACAAA 3=;
Srec1, forward primer 5= GACTGGACCCGAAGGACA 3= and reverse primer 5= CGAGCCCAAGTTGGTGAG 3=;
CAR, forward primer 5= CCCTGGGGTTGCAAATAAG 3= and reverse primer 5= GATCCATCCACGAAGCA
TCT 3=; actin, forward primer 5= GTCCACACCCGCCACCAGTTCG 3= and reverse primer 5= GGAATACAGC
CCGGGGAGCATCGTC 3=. Data were normalized to -actin expression and plotted on a relative scale for
each gene by setting the cells with the highest level of expression to 100%.
Data analysis, Pearson correlation, and statistics. Data were analyzed with GraphPad Prism 5.0
software. Data are presented as mean values, and error bars show the standard errors of the means.
Statistical signiﬁcance was calculated with the unpaired t test (*, P  0.05; **, P  0.01; ***, P  0.001).
If not stated otherwise, representative results of at least three independent experiments are shown.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00670-17.
FIG S1, PDF ﬁle, 0.2 MB.
FIG S2, PDF ﬁle, 0.4 MB.
FIG S3, PDF ﬁle, 0.2 MB.
FIG S4, PDF ﬁle, 0.2 MB.
FIG S5, PDF ﬁle, 0.3 MB.
FIG S6, PDF ﬁle, 0.5 MB.
ACKNOWLEDGMENTS
We thank J. Ippisch, P. Lüderitz, M. Mitterer, M. Kauffmann, and A. Fodor for technical
assistance and T. Wilhelm for technical instructions. We thank P. Stäheli and A. Babler
for organizational help. We are deeply thankful to C. Galanos for discussions and
continuous support. C.G. passed away on 9 July 2015.
G.F. received ﬁnancial support from the NC3Rs (NC/L00058X/1), and W.W.S. received
Maler et al. ®
July/August 2017 Volume 8 Issue 4 e00670-17 mbio.asm.org 12
ﬁnancial support from the Deutsche Forschungsgemeinschaft (DFG) through EXC294
(BIOSS Centre for Biological Signalling Studies). I.C. was supported by an Alexander von
Humboldt fellowship. U.F.G., M.S., and N.S. were supported by the Swiss National
Science Foundation (310030B_160316) and the European Commission Initial Training
Network (FP7; ADVance no. 290002). M.A.F. and M.H. were supported in part by a grant
from the Leonardis foundation. The funders had no role in study design, data collection
and interpretation, or the decision to submit the work for publication.
REFERENCES
1. Goubau D, Deddouche S, Reis e Sousa C. 2013. Cytosolic sensing of
viruses. Immunity 38:855–869. https://doi.org/10.1016/j.immuni.2013.05
.007.
2. Mercer J, Greber UF. 2013. Virus interactions with endocytic pathways in
macrophages and dendritic cells. Trends Microbiol 21:380–388. https://
doi.org/10.1016/j.tim.2013.06.001.
3. Gordon S, Plüddemann A, Martinez Estrada F. 2014. Macrophage heter-
ogeneity in tissues: phenotypic diversity and functions. Immunol Rev
262:36–55. https://doi.org/10.1111/imr.12223.
4. Yamauchi Y, Greber UF. 2016. Principles of virus uncoating: cues and the
snooker ball. Trafﬁc 17:569–592.
5. Bell J, McFadden G. 2014. Viruses for tumor therapy. Cell Host Microbe
15:260–265. https://doi.org/10.1016/j.chom.2014.01.002.
6. Rollier CS, Reyes-Sandoval A, Cottingham MG, Ewer K, Hill AVS. 2011.
Viral vectors as vaccine platforms: deployment in sight. Curr Opin Im-
munol 23:377–382. https://doi.org/10.1016/j.coi.2011.03.006.
7. Appaiahgari MB, Vrati S. 2015. Adenoviruses as gene/vaccine delivery
vectors: promises and pitfalls. Expert Opin Biol Ther 15:337–351. https://
doi.org/10.1517/14712598.2015.993374.
8. Wold WSM, Toth K. 2013. Adenovirus vectors for gene therapy, vaccina-
tion and cancer gene therapy. Curr Gene Ther 13:421–433. https://doi
.org/10.2174/1566523213666131125095046.
9. Hendrickx R, Stichling N, Koelen J, Kuryk L, Lipiec A, Greber UF. 2014.
Innate immunity to adenovirus. Hum Gene Ther 25:265–284. https://doi
.org/10.1089/hum.2014.001.
10. Lütschg V, Boucke K, Hemmi S, Greber UF. 2011. Chemotactic antiviral
cytokines promote infectious apical entry of human adenovirus into
polarized epithelial cells. Nat Commun 2:391. https://doi.org/10.1038/
ncomms1391.
11. Fejer G, Freudenberg M, Greber UF, Gyory I. 2011. Adenovirus-triggered
innate signalling pathways. Eur J Microbiol Immunol 1:279–288. https://
doi.org/10.1556/EuJMI.1.2011.4.3.
12. Wolfrum N, Greber UF. 2013. Adenovirus signalling in entry. Cell Micro-
biol 15:53–62. https://doi.org/10.1111/cmi.12053.
13. Burckhardt CJ, Suomalainen M, Schoenenberger P, Boucke K, Hemmi S,
Greber UF. 2011. Drifting motions of the adenovirus receptor CAR and
immobile integrins initiate virus uncoating and membrane lytic protein
exposure. Cell Host Microbe 10:105–117. https://doi.org/10.1016/j.chom
.2011.07.006.
14. Wiethoff CM, Nemerow GR. 2015. Adenovirus membrane penetration:
tickling the tail of a sleeping dragon. Virology 479–480:591–599. https://
doi.org/10.1016/j.virol.2015.03.006.
15. Suomalainen M, Greber UF. 2013. Uncoating of non-enveloped viruses.
Curr Opin Virol 3:27–33. https://doi.org/10.1016/j.coviro.2012.12.004.
16. Luisoni S, Suomalainen M, Boucke K, Tanner LB, Wenk MR, Guan XL,
Grzybek M, Coskun Ü, Greber UF. 2015. Co-option of membrane wound-
ing enables virus penetration into cells. Cell Host Microbe 18:75–85.
https://doi.org/10.1016/j.chom.2015.06.006.
17. Flatt JW, Greber UF. 2015. Misdelivery at the nuclear pore complex—
stopping a virus dead in its tracks. Cells 4:277–296. https://doi.org/10
.3390/cells4030277.
18. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM,
Denby L, Kemball-Cook G, Ni S, Lieber A, McVey JH, Nicklin SA, Baker AH.
2006. Multiple vitamin K-dependent coagulation zymogens promote
adenovirus-mediated gene delivery to hepatocytes. Blood 108:
2554–2561. https://doi.org/10.1182/blood-2006-04-008532.
19. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A. 2005. Adenovirus
binding to blood factors results in liver cell infection and hepatotoxicity.
J Virol 79:7478–7491. https://doi.org/10.1128/JVI.79.12.7478-7491.2005.
20. Cotter MJ, Zaiss AK, Muruve DA. 2005. Neutrophils interact with adeno-
virus vectors via Fc receptors and complement receptor 1. J Virol 79:
14622–14631. https://doi.org/10.1128/JVI.79.23.14622-14631.2005.
21. Xu Z, Tian J, Smith JS, Byrnes AP. 2008. Clearance of adenovirus by Kupffer
cells is mediated by scavenger receptors, natural antibodies, and comple-
ment. J Virol 82:11705–11713. https://doi.org/10.1128/JVI.01320-08.
22. Adams WC, Bond E, Havenga MJE, Holterman L, Goudsmit J, Karlsson
Hedestam GB, Koup RA, Loré K. 2009. Adenovirus serotype 5 infects
human dendritic cells via a coxsackievirus–adenovirus receptor-
independent receptor pathway mediated by lactoferrin and DC-SIGN. J
Gen Virol 90:1600–1610. https://doi.org/10.1099/vir.0.008342-0.
23. Haisma HJ, Boesjes M, Beerens AM, van der Strate BWA, Curiel DT,
Plüddemann A, Gordon S, Bellu AR. 2009. Scavenger receptor A: a new
route for adenovirus 5. Mol Pharm 6:366–374. https://doi.org/10.1021/
mp8000974.
24. Piccolo P, Vetrini F, Mithbaokar P, Grove NC, Bertin T, Palmer D, Ng P,
Brunetti-Pierri N. 2013. SR-A and SREC-I are Kupffer and endothelial cell
receptors for helper-dependent adenoviral vectors. Mol Ther 21:
767–774. https://doi.org/10.1038/mt.2012.287.
25. Khare R, Reddy VS, Nemerow GR, Barry MA. 2012. Identiﬁcation of
adenovirus serotype 5 hexon regions that interact with scavenger re-
ceptors. J Virol 86:2293–2301. https://doi.org/10.1128/JVI.05760-11.
26. Doronin K, Flatt JW, Di Paolo NCD, Khare R, Kalyuzhniy O, Acchione M,
Sumida JP, Ohto U, Shimizu T, Akashi-Takamura S, Miyake K, MacDonald
JW, Bammler TK, Beyer RP, Farin FM, Stewart PL, Shayakhmetov DM.
2012. Coagulation factor X activates innate immunity to human species
C adenovirus. Science 338:795–798. https://doi.org/10.1126/science
.1226625.
27. Appledorn DM, Patial S, McBride A, Godbehere S, Van Rooijen NV,
Parameswaran N, Amalﬁtano A. 2008. Adenovirus vector-induced innate
inﬂammatory mediators, MAPK signaling, as well as adaptive immune
responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol
181:2134–2144. https://doi.org/10.4049/jimmunol.181.3.2134.
28. Fejer G, Drechsel L, Liese J, Schleicher U, Ruzsics Z, Imelli N, Greber UF,
Keck S, Hildenbrand B, Krug A, Bogdan C, Freudenberg MA. 2008. Key
role of splenic myeloid DCs in the IFN- response to adenoviruses in
vivo. PLoS Pathog 4. https://doi.org/10.1371/journal.ppat.1000208.
29. Lam E, Stein S, Falck-Pedersen E. 2014. Adenovirus detection by the
cGAS/STING/TBK1 DNA sensing cascade. J Virol 88:974–981. https://doi
.org/10.1128/JVI.02702-13.
30. Lau L, Gray EE, Brunette RL, Stetson DB. 2015. DNA tumor virus onco-
genes antagonize the cGAS-STING DNA-sensing pathway. Science 350:
568–571. https://doi.org/10.1126/science.aab3291.
31. Fejer G, Wegner MD, Györy I, Cohen I, Engelhard P, Voronov E, Manke T,
Ruzsics Z, Dölken L, Prazeres da Costa O, Branzk N, Huber M, Prasse A,
Schneider R, Apte RN, Galanos C, Freudenberg MA. 2013. Nontrans-
formed, GM-CSF-dependent macrophage lines are a unique model to
study tissue macrophage functions. Proc Natl Acad Sci U S A 110:
E2191–E2198. https://doi.org/10.1073/pnas.1302877110.
32. Areschoug T, Gordon S. 2009. Scavenger receptors: role in innate im-
munity and microbial pathogenesis. Cell Microbiol 11:1160–1169.
https://doi.org/10.1111/j.1462-5822.2009.01326.x.
33. Imelli N, Ruzsics Z, Puntener D, Gastaldelli M, Greber UF. 2009. Genetic
reconstitution of the human adenovirus type 2 temperature-sensitive 1
mutant defective in endosomal escape. Virol J 6:174. https://doi.org/10
.1186/1743-422X-6-174.
34. Buehler E, Chen YC, Martin S. 2012. C911: a bench-level control for
sequence speciﬁc siRNA off-target effects. PLoS One 7:e51942. https://
doi.org/10.1371/journal.pone.0051942.
35. Palecanda A, Paulauskis J, Al-Mutairi E, Imrich A, Qin G, Suzuki H,
Kodama T, Tryggvason K, Koziel H, Kobzik L. 1999. Role of the scavenger
receptor MARCO in alveolar macrophage binding of unopsonized envi-
MARCO-Mediated Adenovirus Infection and Innate Response ®
July/August 2017 Volume 8 Issue 4 e00670-17 mbio.asm.org 13
ronmental particles. J Exp Med 189:1497–1506. https://doi.org/10.1084/
jem.189.9.1497.
36. Di Paolo NC, Miao EA, Iwakura Y, Kaja M-K, Aderem A, Flavell RA,
Papayannopoulou T, Shayakhmetov DM. 2009. Virus sensing at the
plasma membrane triggers interleukin-1–mediated pro-inﬂammatory
macrophage response in vivo. Immunity 31:110–121. https://doi.org/10
.1016/j.immuni.2009.04.015.
37. Di Paolo NC, Baldwin LK, Irons EE, Papayannopoulou T, Tomlinson S,
Shayakhmetov DM. 2014. IL-1 and complement cooperate in triggering
local neutrophilic inﬂammation in response to adenovirus and eliminat-
ing virus-containing cells. PLoS Pathog 10:e1004035. https://doi.org/10
.1371/journal.ppat.1004035.
38. Yamaguchi T, Kawabata K, Koizumi N, Sakurai F, Nakashima K, Sakurai H,
Sasaki T, Okada N, Yamanishi K, Mizuguchi H. 2007. Role of MyD88 and
TLR9 in the innate immune response elicited by serotype 5 adenoviral
vectors. Hum Gene Ther 18:753–762. https://doi.org/10.1089/hum.2007
.016.
39. Zsengellér Z, Otake K, Hossain SA, Berclaz PY, Trapnell BC. 2000. Inter-
nalization of adenovirus by alveolar macrophages initiates early proin-
ﬂammatory signaling during acute respiratory tract infection. J Virol
74:9655–9667. https://doi.org/10.1128/JVI.74.20.9655-9667.2000.
40. van der Laan LJ, Döpp EA, Haworth R, Pikkarainen T, Kangas M, Elomaa
O, Dijkstra CD, Gordon S, Tryggvason K, Kraal G. 1999. Regulation and
functional involvement of macrophage scavenger receptor MARCO in
clearance of bacteria in vivo. J Immunol 162:939–947.
41. Nociari M, Ocheretina O, Schoggins JW, Falck-Pedersen E. 2007. Sensing
infection by adenovirus: Toll-like receptor-independent viral DNA rec-
ognition signals activation of the interferon regulatory Factor 3 master
regulator. J Virol 81:4145–4157. https://doi.org/10.1128/JVI.02685-06.
42. Cohen I, Rider P, Carmi Y, Braiman A, Dotan S, White MR, Voronov E,
Martin MU, Dinarello CA, Apte RN. 2010. Differential release of
chromatin-bound IL-1alpha discriminates between necrotic and apopto-
tic cell death by the ability to induce sterile inﬂammation. Proc Natl Acad
Sci U S A 107:2574–2579. https://doi.org/10.1073/pnas.0915018107.
43. Afonina IS, Tynan GA, Logue SE, Cullen SP, Bots M, Lüthi AU, Reeves EP,
McElvaney NG, Medema JP, Lavelle EC, Martin SJ. 2011. Granzyme
B-dependent proteolysis acts as a switch to enhance the proinﬂammatory
activity of IL-1. Mol Cell 44:265–278. https://doi.org/10.1016/j.molcel.2011
.07.037.
44. Marcos MA, Esperatti M, Torres A. 2009. Viral pneumonia. Curr Opin
Infect Dis 22:143–147. https://doi.org/10.1097/QCO.0b013e328328cf65.
45. Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales
J, Derrick SC, Shi R, Kumar NP, Wei W, Yuan X, Zhang G, Cai Y, Babu S,
Catalfamo M, Salazar AM, Via LE, Barry CE, III, Sher A. 2014. Host-directed
therapy of tuberculosis based on interleukin-1 and type I interferon
crosstalk. Nature 511:99–103. https://doi.org/10.1038/nature13489.
46. Caffrey AK, Lehmann MM, Zickovich JM, Espinosa V, Shepardson KM,
Watschke CP, Hilmer KM, Thammahong A, Barker BM, Rivera A, Cramer
RA, Obar JJ. 2015. IL-1 signaling is critical for leukocyte recruitment
after pulmonary Aspergillus fumigatus challenge. PLoS Pathog 11:
e1004625. https://doi.org/10.1371/journal.ppat.1004625.
47. MacLeod DT, Nakatsuji T, Wang Z, di Nardo A, Gallo RL. 2015. Vaccinia
virus binds to the scavenger receptor MARCO on the surface of keratin-
ocytes. J Invest Dermatol 135:142–150. https://doi.org/10.1038/jid.2014
.330.
48. MacLeod DT, Nakatsuji T, Yamasaki K, Kobzik L, Gallo RL. 2013. HSV-1
exploits the innate immune scavenger receptor MARCO to enhance
epithelial adsorption and infection. Nat Commun 4:1963. https://doi.org/
10.1038/ncomms2963.
49. Ghosh S, Gregory D, Smith A, Kobzik L. 2011. MARCO regulates early
inﬂammatory responses against inﬂuenza: a useful macrophage function
with adverse outcome. Am J Respir Cell Mol Biol 45:1036–1044. https://
doi.org/10.1165/rcmb.2010-0349OC.
50. Chen Y, Wermeling F, Sundqvist J, Jonsson AB, Tryggvason K, Pikkara-
inen T, Karlsson MCI. 2010. A regulatory role for macrophage class A
scavenger receptors in TLR4-mediated LPS responses. Eur J Immunol
40:1451–1460. https://doi.org/10.1002/eji.200939891.
51. Bowdish DME, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer
CA, Tryggvason K, Gordon S, Russell DG. 2009. MARCO, TLR2, and CD14
are required for macrophage cytokine responses to mycobacterial tre-
halose dimycolate and Mycobacterium tuberculosis. PLoS Pathog
5:e1000474. https://doi.org/10.1371/journal.ppat.1000474.
52. Fejér G, Szalay K, Gyory I, Fejes M, Kúsz E, Nedieanu S, Páli T, Schmidt T,
Siklódi B, Lázár G, Lázár G, Duda E. 2005. Adenovirus infection dramat-
ically augments lipopolysaccharide-induced TNF production and sensi-
tizes to lethal shock. J Immunol 175:1498–1506. https://doi.org/10.4049/
jimmunol.175.3.1498.
53. Freudenberg MA, Kalis C, Chvatchko Y, Merlin T, Gumenscheimer M,
Galanos C. 2003. Role of interferons in LPS hypersensitivity. J Endotoxin
Res 9:308–312.
54. Freudenberg MA, Tchaptchet S, Keck S, Fejer G, Huber M, Schütze N,
Beutler B, Galanos C. 2008. Lipopolysaccharide sensing an important
factor in the innate immune response to Gram-negative bacterial
infections: beneﬁts and hazards of LPS hypersensitivity. Immunobiology
213:193–203. https://doi.org/10.1016/j.imbio.2007.11.008.
55. Weber FC, Németh T, Csepregi JZ, Dudeck A, Roers A, Ozsvári B, Oswald E,
Puskás LG, Jakob T, Mócsai A, Martin SF. 2015. Neutrophils are required for
both the sensitization and elicitation phase of contact hypersensitivity. J Exp
Med 212:15–22. https://doi.org/10.1084/jem.20130062.
56. Li PZ, Li JZ, Li M, Gong JP, He K. 2014. An efﬁcient method to isolate and
culture mouse Kupffer cells. Immunol Lett 158:52–56. https://doi.org/10
.1016/j.imlet.2013.12.002.
57. Fejer G, Gyory I, Tufariello J, Horwitz MS. 1994. Characterization of
transgenic mice containing adenovirus early region 3 genomic DNA. J
Virol 68:5871–5881.
58. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi
J, Yaswen P, Cooper PK, Kaufman PD. 2009. A versatile viral system for
expression and depletion of proteins in mammalian cells. PLoS One
4:e6529. https://doi.org/10.1371/journal.pone.0006529.
59. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP
is an endogenous second messenger in innate immune signaling by
cytosolic DNA. Science 339:826–830. https://doi.org/10.1126/science
.1229963.
Maler et al. ®
July/August 2017 Volume 8 Issue 4 e00670-17 mbio.asm.org 14
